Stay Up to Date! Like us on Facebook  and Twitter  for the latest news and announcements    

Board of Directors

Meet the MitoAction Board of Directors: People committed to improving the everyday lives of those affected by mitochondrial disease

Executive Committee and Board of Directors

Philip Borden, President

Philip Borden is  Managing Partner for Galen Partners. Prior to Galen, Philip was with Riverside Partners, a private equity firm based in Boston, where he was responsible for the firm's investments in healthcare companies. Philip attended Duke University and earned an MBA from Harvard Business School, where he was a Baker Scholar.

Philip has lived in the Greater Boston area for more than a decade and currently resides in Cambridge with his wife, Catherine. Catherine suffers from mitochondrial disease, and Philip became involved with MitoAction following her diagnosis. Catherine and Philip have a vizsla named Rummy, who brings them lots of joy (but sometimes chews their furniture and shoes).

Gordon Russell, Vice President

Gordon Russell is a native Bostonian. He grew up in Weston, MA and attended Hobart College and the Boston University School of Fine Arts. He lost his wife, Sandra, to MELAS in 2008. Gordon is the owner of In The Pink Stores Inc., which he and Sandra founded in 1996. In The Pink operates six retail clothing stores in Massachusetts. Gordon has two children, Buck and Jonathan, and resides in Wellesley, MA. During Sandra's struggle with MELAS, Gordon and his boys experienced firsthand the support and guidance provided by MitoAction and came to fully understand how critical a role the organization plays. Gordon is serving on the MitoAction board to support MitoAction's evolution and to ensure MitoAction will always be positioned to provide vital support to individuals and families affected by mitochondrial disease.

Tom Keery, Secretary

Thomas R. Keery, II is the General Partner of the Keery Family Limited Partnership, a real estate partnership with commercial and residential properties in Massachusetts. Prior to entering the real estate business, Tom was president of Frost Motors Inc., a Newton, MA dealership holding company. In operation since 1934, Tom joined the family business upon his graduation from Ithaca College in 1975 with a degree in Communications. Since 1985, Tom had been the Dealer Principal, and had successfully grown the business, acquiring and selling several dealerships. In 2002, he was named the Massachusetts recipient of Time Magazine's Quality Dealer Award, which is given annually to automobile dealers in recognition of their leadership in community and Industry affairs.

Tom is a member and past president of the Rotary Club of Newton, a member ofSt. Peter's Church in Weston, a past director and officer of the YMCA, and a member and past director of the Newton Needham Chamber of Commerce. He is also a member of the Newton Elks. Tom's sister Sandra passed away in 2008 due to MELAS.

Born in Newton in 1953, Tom resides in Weston with his wife, Laura, where they raised their four children. He enjoys golf and cycling.

Paul Harty

Paul Harty became president of Seven Step Recruiting in 2008. Seven Step is a leading provider of large-scale hiring solutions, using a unique team-based model of RPO services delivery. Paul is responsible for the company's strategic direction, and oversees the delivery of all client solutions. Prior to joining Seven Step, Paul spent 15 years building and managing a successful technology recruiting and placement businesses. He lives in the Boston area with his wife and children. His son, Matthew, died of Pyruvate Dehydrogenase Deficiency at the age of 8. While searching for answers for his son's disabilities and managing through a long diagnosis process, Paul discovered MitoAction as a strong support system and a way to gain knowledge about Mito. Paul became an active member to guarantee that other caregivers or patients who are faced with Mito have access to continued support and knowledge that is so necessary when dealing with rare disease.

Jessica Fein

Jessie is the vice president of corporate marketing and creative services for Bright Horizons, the world’s leading provider of employer-sponsored child care and work/life solutions. She is a former opinion columnist for the Sunday Boston Globe and is the author of "Moving On: How to Make the Transition from College to the Real World." Prior to working at Bright Horizons, Jessie ran her own writing business, Fein Print. Jessie is the mom of three incredible children, Jonah, Dalia, and Theo. Dalia has the mitochondrial disease MERRF Syndrome.

Click here to read more about Jessie!

Marie A. Grant

Marie grew up in Weston, MA and began her career in finance and accounting at the Seaport Hotel in Boston. She recently made a career move to the Mobile Advertising industry and is currently working as the Accounting Manager at Adelphic Mobile, Inc. She was inspired to volunteer for MitoAction when a family friend, Sandra Russell, needed support during her battle with MELAS. Since her first walk with Sandra’s Stars, Marie has been an active volunteer at Boston area events, including managing the betting tables during the Sandra K. Russell Derby Day Benefit for Mito. As a young professional, it is her hope to be able to engage others and teach them about the importance of MitoAction to the mitochondrial disease community.

Saad Dinno, RPh

Saad Dinno, RPh, FIACP, FACA, has given lectures on mitochondrial disease across the country as well as in Australia. His staff works with patients and their providers on insurance coverage issues, compliance, taste, dosage form, counseling on the medications being dispensed, and other relevant Mito information and general questions.

He is a member of the Massachusetts Independent Pharmacy Association, Massachusetts Pharmacist Association, National Community Pharmacist Association, and International Academy of Compounding Pharmacists. He is the past president of the Massachusetts Independent Pharmacy Association and previously served on the Professional Compounding Centers of America (PCCA) Advisory Board.

Saad has received numerous awards, including being named the Margaret Bauman Outstanding Medical Professional for his work serving the autism community.

He was also named Massachusetts Innovative Pharmacist of the Year, PCCA Pharmacist of the Month, and received a Fellowship distinction from the International Academy of Compounding Pharmacists. Additionally, Saad serves on Emerson Hospital’s Care Transition Collaborative Committee, the Eliot Community Human Rights Committee, Cardinal Distribution East Advisory Board and the MitoAction Marcel Way Fund Committee. He received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Health Sciences.

Andrew Nierenberg, MD

Dr. Nierenberg is Professor of Psychiatry, Harvard Medical School, Co-Director of the Bipolar Clinic and Research Program, and Associate Director of the Depression Clinical and Research Program, Massachusetts General Hospital (MGH). He attended the Albert Einstein College of Medicine of Yeshiva University followed by a residency in psychiatry at New York University/Bellevue Hospital and then became a Robert Wood Johnson Clinical Scholar at Yale University. In 1992, he joined the Psychiatry Department at MGH. He has published over 250 original articles and over 60 reviews, editorials, and chapters, and has been listed among the Best Doctors in North America for the treatment of mood and anxiety disorders continuously since 1994. He received the NDMDA Gerald L. Klerman Young Investigator Award and was elected as a member of the American College of Neuropsychopharmacology (ACNP) and as a Distinguished Fellow of the American Psychiatric Association. His primary interests are treatment resistant depression, bipolar depression, and the longitudinal course of mood disorders.



Medical Advisory Committee

Dr. Katherine B. Sims, MD, CHAIR

Dr. Katherine Sims serves as the Director of the Neurogenetics and Mitochondrial Disorders Clinic at the Massachusetts General Hospital. She also oversees the MGH Mitochondrial Disorders Clinical Registry and BioRepository located in the Center for Human Genetics Research (CHGR) at MGH. She works in research collaboration with Dr. Vamsi Mootha (Broad Institute and CHGR/MGH) toward better genetic and pathobiologic understanding of the energy metabolism/mitochondrial disorders. She received her medical degree from Columbia University College of Physicians and Surgeons and is board-certified in Psychiatry and Neurology with Special Competence in Child Neurology. Dr. Sims is Professor of Neurology at the Harvard Medical School.

Margaret Klehm, Secretary, Medical Advisory Board Member

Margaret R. Klehm, R.N., M.P.H., M.S.N., C.P.N.P., is a nurse practitioner at Dana-Farber Cancer Institute in Cancer Genetics. She also works at Harvard University Health Services and consults for Seasons Palliative Care. She had previously worked in the metabolic program at Tufts Medical Center in Boston, MA. She has worked with patients with metabolic and mitochondrial disease since 1991 at both Children's Hospital and Tufts-New England Medical Center. Prior to that she was a nurse manager on the Bone Marrow Transplant Unit at Brigham and Women's Hospital. She has also worked as a staff nurse on the oncology and bone marrow transplant unit at Children's Hospital in Boston. Margaret graduated from New England Deaconess School of Nursing and the University of Massachusetts in Amherst. In addition she has a Masters in Public Health from Boston University and a Masters of Science in Nursing from Simmons College.

Dr. David Holtzman, MD, PhD

Dr. David Holtzman works in Pediatric Neurology at Massachusetts General Hospital for Chidren. He is board-certified in Pediatrics and Neurology. He is an associate professor in neurology at HMS. He graduated from the University of Chicago Medical School and served his residencies in Pediatrics and Child Neurology at Bronx Municipal Hospital Center and at Albert Einstein College of Medicine in New York. He was Head of Pediatric Neurology at Stanford University and Tulane University.

Dr. Mark Korson, MD

Dr. Korson received his medical degree from the University of Toronto, graduating in 1982. He completed his pediatric training at The Hospital for Sick Children in 1986; this was followed by a genetics and metabolism fellowship at Children's Hospital, Boston (1986-1990). He served as Director of the Inborn Errors of Metabolism Service at Boston Children's Hospital from 1990-2000, and is currently Chief of the Metabolic Service at Boston's Floating Hospital for Children at Tufts Medical Center. He is also associate professor of pediatrics at Tufts University School of Medicine.

Dr. Korson's clinical interests include the management of inherited metabolic disorders (including enzyme replacement and transplantation), the development of teaching methods for training physicians, residents, medical students and community professionals about genetic metabolic diseases, and the development of mechanisms for the long-distance management of patients with these disorders. Dr. Korson has been co-director of the North American Metabolic Academy (NAMA), sponsored by the Society for Inherited Metabolic Diseases (SIMD), since its inception in 2007, and founder and director of the Metabolic Outreach Service since 2007.

Dr. Amy Goldstein, MD

Dr. Goldstein, a member of the Board of Trustees of UMDF, is on faculty at Children’s Hospital of Pittsburgh of UPMC in the Division of Pediatric Neurology. She is board certified in pediatrics, neurology, and psychiatry with Special Qualifications in Child Neurology. She is currently an Assistant Professor at the University of Pittsburgh School of Medicine. She began a multidisciplinary Mitochondrial Disease clinic in 2007 and is now the Director of Neurogenetics & Metabolism and the site Principle Investigator for NAMDC (the North American Mitochondrial Disease Consortium). She is also the President of the Mitochondrial Medicine Society. Her clinical research interests include improving fatigue and exercise intolerance as well as developing common patient-centered outcome measures for clinical trials.

Margaret Orr, MSN EdM FNP-BC

Maggie Orr is the nurse coordinator in the Metabolism Service at Floating Hospital for Children at Tufts Medical Center. She trained as a Family Nurse Practitioner at Yale School of Nursing and worked in primary care for adults and children prior to staying home to care for her daughter, Mamie Rose, who died of mitochondrial disease in 2003. She has undergraduate degrees in Spanish and Early Childhood Education from Arizona State University, and a master's in education from Harvard Graduate School of Education.

Dr. Alex Flores, MD

Dr. Alex Flores is Director and Chair of Ambulatory Community Services and Associate Physician Motility and Gastrointestinal Disorders at Boston Children's Hospital. He is alsoClinical Professor of Pediatrics, Harvard Medical School. Prior to Children's,Dr. Flores was Chief of Pediatric Gastroenterology and Nutrition at Floating Hospital for Children at Tufts Medical Center, Director of the Pediatric Neurodigestive Center at the Floating Hospital for Children, Tufts Medical Center, and Clinical Professor of Pediatrics at Tufts University School of Medicine. He is a graduate of the Universidad de San Carlos de Guatemala School of Medical Sciences, and received graduate training at Baylor College of Medicine, Children's Hospital Boston/Harvard Medical School, Duke University Medical Center, Hospital Militar, Jacaltenango Hospital, Roosevelt Hospital in Guatemala, and the World Health Organization-UNICEF. Dr. Flores is board-certified in Pediatric Gastroenterology and Pediatrics and works closely with Dr. Mark Korson to support metabolic and mitochondrial patients with GI dysfunction. In addition to developing innovative laparoscopic technique for enteral support, Dr. Flores' specialities include GI motility disorders and general pediatric gastroenterology.

Dr. Patricia O'Malley, MD

Dr. Patricia O'Malley has trained in pediatrics, pediatric critical care, emergency medicine and palliative care at Massachusetts General Hospital and Children's Hospital Boston. She has served as the director of the Pediatric ED at MGH for 25 years and is also the director of the Pediatric Palliative Care Team. Dr. O'Malley has worked as part of the coordinated care team for several mitochondrial disease patients.

Dr. Frances Kendall, MD

Dr. Frances Dougherty Kendall trained and served on the staff at Boston Children's Hospital and Harvard Medical School for a number of years. She was the previous 50% owner of a successful genetic laboratory/healthcare provider (Horizon Molecular Medicine), and has extensive experience in the diagnosis and management of children with a wide array of metabolic disorders. She brings this vast experience to her private practice, Virtual Medical Practice, LCC, as president and founder. Dr. Kendall is a well respected pediatrician as well as biochemical geneticist, and she has authored numerous research articles on rare diseases ranging from Nieman Pick Type C and mitochondrial disease. As one of the few clinical mitochondrial disease experts, she has a long-term interest in research and clinical aspects of rare metabolic diseases.

Andrew Nierenberg, MD

Dr. Nierenberg is Professor of Psychiatry, Harvard Medical School, Co-Director of the Bipolar Clinic and Research Program, and Associate Director of the Depression Clinical and Research Program, Massachusetts General Hospital (MGH). He attended the Albert Einstein College of Medicine of Yeshiva University followed by a residency in psychiatry at New York University/Bellevue Hospital and then became a Robert Wood Johnson Clinical Scholar at Yale University. In 1992, he joined the Psychiatry Department at MGH. He has published over 250 original articles and over 60 reviews, editorials, and chapters, and has been listed among the Best Doctors in North America for the treatment of mood and anxiety disorders continuously since 1994. He received the NDMDA Gerald L. Klerman Young Investigator Award and was elected as a member of the American College of Neuropsychopharmacology (ACNP) and as a Distinguished Fellow of the American Psychiatric Association. His primary interests are treatment resistant depression, bipolar depression, and the longitudinal course of mood disorders.